Company intelligence / Profile preview

GenicBio

Shanghai, Shanghai, China

Ownership: Private
Employees: ~25
Development stage: Other

Overview

GenicBio is a private life science tools and research services company focused on custom peptide synthesis, antibody development, and related biochemical products for research use. The company markets catalog peptides, amino acids, amino acid derivatives, and custom synthesis services to research institutions and other life science customers worldwide. Its service offering includes custom peptide synthesis as well as polyclonal and monoclonal antibody development and production. Based on the available public information, GenicBio operates as a commercial research supplier/CRO-style service provider rather than a therapeutic drug developer with a clinical pipeline.

Modalities: PeptidesMonoclonal antibodyAntibodyProtein
Industry: Drug Discovery Services

Beyond the preview

Go deeper on GenicBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenicBio.

Explore the full profile